Albert Luderer Net Worth

Albert Luderer biography

Dr. Albert A. Luderer Ph.D. serves as Independent Director of the Company. Dr. Luderer currently serves as the Chief Executive Officer and a member of the board of directors of Indi Molecular, Inc., a synthetic antibody technology company, and as the Executive Chairman of the board of directors of Prostate Management Diagnostics Inc. Dr. Luderer has over 30 years of experience in executive leadership roles in the areas of technology development, operations and business development. Dr. Luderer received his bachelor’s degree in zoology from Drew University and his MS in immunochemistry and Ph.D. in immunogenics from Rutgers University. Our board of directors believes Dr. Luderer’s experience in the biotechnology sector, with special focuses on technology, business development and commercialization, qualifies him to serve on our board of directors.

How old is Albert Luderer?

Albert Luderer is 71, he's been the Independent Director of Bionano Genomics Inc since 2011. There are 1 older and 7 younger executives at Bionano Genomics Inc. The oldest executive at Bionano Genomics Inc is David Barker, 78, who is the Independent Chairman of the Board.

What's Albert Luderer's mailing address?

Albert's mailing address filed with the SEC is C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA, 92121.

Insiders trading at Bionano Genomics Inc

Over the last 6 years, insiders at Bionano Genomics Inc have traded over $0 worth of Bionano Genomics Inc stock and bought 145,814 units worth $129,149 . The most active insiders traders include David L Barker, Christopher P. Stewart und Christopher J Twomey. On average, Bionano Genomics Inc executives and independent directors trade stock every 75 days with the average trade being worth of $15,253. The most recent stock trade was executed by Hannah Mamuszka on 13 June 2023, trading 65,789 units of BNGO stock currently worth $50,000.

What does Bionano Genomics Inc do?

at bionano genomics®, we are committed to unlocking understanding of genome biology to advance the promise of genomics in areas including cancer and human disease, agricultural bioengineering and genome discovery. our team is not afraid to venture into uncharted territory to look for answers. we welcome the curious and provide a place where those who are not satisfied with the status quo can feel at home. our next-generation genome mapping and analysis tools help researchers see true genome structure to fill in what’s missing from sequencing-based data. saphyr™, our high-speed, high-throughput whole genome mapping solution, offers unmatched structural variation discovery capabilities and the ability to construct the most complete genome assemblies. at bionano, we are invested in the success of our customers and users around the world, and are dedicated to supporting them with the tools, resources and support they need to achieve their goals and make a real impact on improving quality o

Bionano Genomics Inc executives and stock owners

Bionano Genomics Inc executives and other stock owners filed with the SEC include:

• R. Erik Holmlin,
  President, Chief Executive Officer, Director
• Mark Oldakowski,
  Chief Operating Officer
• Dr. Robert Erik Holmlin,
  Pres, CEO, Sec. & Director
• David Barker,
  Independent Chairman of the Board
• Christopher P. Stewart,
  Chief Financial Officer
• Kristiina Vuori,
  Independent Director
• Christopher Twomey,
  Independent Director
• Albert Luderer,
  Independent Director
• Hannah Mamuszka,
  Director
• Yvonne Linney,
  Director
• Alka Chaubey,
  Chief Medical Officer
• Christopher Stewart,
  Chief Financial Officer
• Dr. Charles Lee Ph.D.,
  Scientific Advisor
• Prof. Pui-Yan Kwok,
  Scientific Advisor
• Dr. Paul R. Selvin Ph.D.,
  Scientific Advisor
• Mark Adamchak,
  Controller
• Richard Shippy,
  Chief Bus. Officer
• Robert J. Priar,
  Chief Commercial Officer
• Dr. Alka Chaubey FACMG, Ph.D.,
  Chief Medical Officer
• Aleksandar Rajkovic,
  Director
• Robert J Priar,
  Chief Commercial Officer
• Michael James Ward,
  Former Chief Financial Officer
• Heather Adams,
  Chief Administrative Officer
• Warren Robinson,
  Chief Commercial Officer
• Darren Cai,
  Director
• Quan Zhou,
  Director
• Junfeng Wang,
  Director
• Soheil Shams,
  Chief Informatics Officer
• Richard Shippy,
  Chief Business Officer
• Vincent Jung Fai Wong,
  Director
• Jonathan V. Dixon,
  GENERAL COUNSEL
• Gulsen Kama,
  Chief Financial Officer